Breaking News Instant updates and real-time market news.

INGR

Ingredion

$100.65 /

-0.835 (-0.82%)

06:06
02/08/23
02/08
06:06
02/08/23
06:06

Ingredion reports Q4 adjusted EPS $1.65, consensus $1.45

Reports Q4 revenue $1.99B, consensus $2.04B.

  • 08

    Feb

OTHER BREAKING NEWS FROM THE FLY

Recommendations
SL Green Realty price target lowered to $17 from $35 at Citi » 19:21
03/27/23
03/27
19:21
03/27/23
19:21
SLG

SL Green Realty

$20.31 /

-0.17 (-0.83%)

Citi analyst Nicholas…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
SLG SL Green Realty
$20.31 /

-0.17 (-0.83%)

SLG SL Green Realty
$20.31 /

-0.17 (-0.83%)

09:39 Today Evercore ISI
SL Green Realty price target lowered to $33 from $38 at Evercore ISI
03/23/23 Barclays
SL Green Realty downgraded to Underweight from Equal Weight at Barclays
03/21/23 Goldman Sachs
SL Green Realty resumed with a Sell at Goldman Sachs
03/21/23 Piper Sandler
SL Green Realty price target lowered to $27 from $42 at Piper Sandler
SLG SL Green Realty
$20.31 /

-0.17 (-0.83%)

SLG SL Green Realty
$20.31 /

-0.17 (-0.83%)

SLG SL Green Realty
$20.31 /

-0.17 (-0.83%)

Initiation
Ingenia Communities initiated with a Buy at Citi » 19:19
03/27/23
03/27
19:19
03/27/23
19:19
INGEF

Ingenia Communities

$2.21 /

-0.04 (-1.78%)

Citi initiated coverage…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
INGEF Ingenia Communities
$2.21 /

-0.04 (-1.78%)

01/13/23 JPMorgan
Ingenia Communities initiated with a Neutral at JPMorgan
Recommendations
Joann price target lowered to $1 from $3.50 at BofA » 19:19
03/27/23
03/27
19:19
03/27/23
19:19
JOAN

Joann

$1.78 /

-0.03 (-1.66%)

BofA analyst Elizabeth…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
JOAN Joann
$1.78 /

-0.03 (-1.66%)

JOAN Joann
$1.78 /

-0.03 (-1.66%)

03/24/23 Loop Capital
Joann price target lowered to $2 from $4 at Loop Capital
12/14/22 Barclays
Joann price target lowered to $3 from $5 at Barclays
12/13/22 Loop Capital
Joann price target lowered to $4 from $7 at Loop Capital
09/02/22 Wells Fargo
Joann price target lowered to $4 from $5 at Wells Fargo
JOAN Joann
$1.78 /

-0.03 (-1.66%)

JOAN Joann
$1.78 /

-0.03 (-1.66%)

JOAN Joann
$1.78 /

-0.03 (-1.66%)

Downgrade
Alps Alpine downgraded to Neutral from Buy at Citi » 19:18
03/27/23
03/27
19:18
03/27/23
19:18
APELY

Alps Alpine

$19.00 /

-0.39 (-2.01%)

Citi analyst Takayuki…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
APELY Alps Alpine
$19.00 /

-0.39 (-2.01%)

04/13/22 Goldman Sachs
Alps Alpine upgraded to Buy from Neutral at Goldman Sachs
Recommendations
BioNTech price target lowered to $194 from $239 at BofA » 19:17
03/27/23
03/27
19:17
03/27/23
19:17
BNTX

BioNTech

$123.50 /

-4.63 (-3.61%)

BofA lowered the…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
BNTX BioNTech
$123.50 /

-4.63 (-3.61%)

BNTX BioNTech
$123.50 /

-4.63 (-3.61%)

03/23/23 H.C. Wainwright
BioNTech price target lowered to $210 from $272 at H.C. Wainwright
12/15/22 BofA
BioNTech upgraded to Buy at BofA oncology pipeline opportunities
12/15/22 BofA
BioNTech upgraded to Buy from Neutral at BofA
11/08/22 Canaccord
BioNTech price target lowered to $191 from $200 at Canaccord
BNTX BioNTech
$123.50 /

-4.63 (-3.61%)

BNTX BioNTech
$123.50 /

-4.63 (-3.61%)

BNTX BioNTech
$123.50 /

-4.63 (-3.61%)

Recommendations
Amicus price target raised to $17 from $16 at BofA » 19:16
03/27/23
03/27
19:16
03/27/23
19:16
FOLD

Amicus

$11.09 /

+0.005 (+0.05%)

BofA analyst Tazeen Ahmad…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
FOLD Amicus
$11.09 /

+0.005 (+0.05%)

FOLD Amicus
$11.09 /

+0.005 (+0.05%)

03/10/23 Stifel
Stifel says SVB fallout 'appears limited' across firm's biotech coverage
01/18/23 BTIG
Amicus price target raised to $16 from $14 at BTIG
09/09/22 Morgan Stanley
Amicus initiated with an Equal Weight at Morgan Stanley
04/13/22 Goldman Sachs
Amicus reinstated with a Neutral at Goldman Sachs
FOLD Amicus
$11.09 /

+0.005 (+0.05%)

FOLD Amicus
$11.09 /

+0.005 (+0.05%)

Recommendations
Tencent price target raised to $50 from $48 at Barclays » 19:14
03/27/23
03/27
19:14
03/27/23
19:14
TCEHY

Tencent

$46.19 /

-1.66 (-3.47%)

Barclays analyst Jiong…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
TCEHY Tencent
$46.19 /

-1.66 (-3.47%)

TCEHY Tencent
$46.19 /

-1.66 (-3.47%)

01/25/23 Barclays
Tencent price target raised to $48 from $36 at Barclays
01/05/23 Mizuho
Tencent price target raised to HK$330 from HK$300 at Mizuho
11/02/22 Morgan Stanley
Tencent named a 'Catalyst Driven Idea' at Morgan Stanley
10/28/22 Barclays
Tencent price target lowered to $31 from $44 at Barclays
TCEHY Tencent
$46.19 /

-1.66 (-3.47%)

TCEHY Tencent
$46.19 /

-1.66 (-3.47%)

Recommendations
Lululemon price target lowered to $368 from $394 at Barclays » 19:13
03/27/23
03/27
19:13
03/27/23
19:13
LULU

Lululemon

$317.32 /

+3.68 (+1.17%)

Barclays lowered the…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
LULU Lululemon
$317.32 /

+3.68 (+1.17%)

LULU Lululemon
$317.32 /

+3.68 (+1.17%)

03/24/23 TD Cowen
Lululemon price target lowered to $470 from $488 at TD Cowen
03/24/23 Citi
Citi opens 'positive Catalyst Watch' on Lululemon into earnings
03/23/23 Goldman Sachs
Goldman checks constructive on Lululemon 'brand heat' and traffic
03/23/23 Jefferies
Jefferies says Lululemon policy change shows markdown issues
LULU Lululemon
$317.32 /

+3.68 (+1.17%)

LULU Lululemon
$317.32 /

+3.68 (+1.17%)

LULU Lululemon
$317.32 /

+3.68 (+1.17%)

LULU Lululemon
$317.32 /

+3.68 (+1.17%)

Upgrade
Parsons upgraded to Outperform from Market Perform at William Blair » 19:09
03/27/23
03/27
19:09
03/27/23
19:09
PSN

Parsons

$43.10 /

+0.285 (+0.67%)

William Blair analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
PSN Parsons
$43.10 /

+0.285 (+0.67%)

PSN Parsons
$43.10 /

+0.285 (+0.67%)

01/03/23 Morgan Stanley
Parsons downgraded to Underweight from Equal Weight at Morgan Stanley
12/21/22 Baird
Baird starts Parsons at Neutral on valuation despite exposure to growth markets
12/21/22 Baird
Parsons initiated with a Neutral at Baird
12/01/22 BofA
Parsons downgraded to Underperform at BofA after 'strong re-rating'
PSN Parsons
$43.10 /

+0.285 (+0.67%)

Hot Stocks
Liontown Resources rejects Albemarle's A$2.50 per share proposal » 18:59
03/27/23
03/27
18:59
03/27/23
18:59
LINRF

Liontown Resources

$1.03 /

+0.015 (+1.49%)

, ALB

Albemarle

$218.80 /

+1.07 (+0.49%)

On March 27, 2023,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ALB Albemarle
$218.80 /

+1.07 (+0.49%)

LINRF Liontown Resources
$1.03 /

+0.015 (+1.49%)

02/06/23 UBS
Liontown Resources initiated with a Buy at UBS
01/23/23 JPMorgan
Liontown Resources upgraded to Overweight from Neutral at JPMorgan
12/07/22 Goldman Sachs
Liontown Resources initiated with a Neutral at Goldman Sachs
ALB Albemarle
$218.80 /

+1.07 (+0.49%)

03/17/23 Loop Capital
Albemarle price target raised to $403 from $397 at Loop Capital
03/16/23 Deutsche Bank
Deutsche takes 'cautious tone' on lithium stocks near term
03/08/23 Citi
Tesla comments 'very bullish' for lithium industry, says Citi
02/21/23 Piper Sandler
Albemarle price target raised to $330 from $310 at Piper Sandler
ALB Albemarle
$218.80 /

+1.07 (+0.49%)

ALB Albemarle
$218.80 /

+1.07 (+0.49%)

ALB Albemarle
$218.80 /

+1.07 (+0.49%)

ALB Albemarle
$218.80 /

+1.07 (+0.49%)

Hot Stocks
AnaptysBio 'encouraged' by GSK phase 3 trial results » 18:54
03/27/23
03/27
18:54
03/27/23
18:54
ANAB

AnaptysBio

$21.89 /

+0.48 (+2.24%)

, GSK

GSK

$35.04 /

+0.65 (+1.89%)

AnaptysBio (ANAB)…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ANAB AnaptysBio
$21.89 /

+0.48 (+2.24%)

GSK GSK
$35.04 /

+0.65 (+1.89%)

ANAB AnaptysBio
$21.89 /

+0.48 (+2.24%)

01/06/23 Raymond James
AnaptysBio downgraded to Market Perform from Outperform at Raymond James
01/06/23 Raymond James
AnaptysBio downgraded to Market Perform from Outperform at Raymond James
11/09/22 Wedbush
AnaptysBio price target raised to $32 from $21 at Wedbush
11/01/22 Guggenheim
AnaptysBio upgraded to Buy at Guggenheim on checkpoint agonist opportunity
GSK GSK
$35.04 /

+0.65 (+1.89%)

03/17/23 Deutsche Bank
GSK upgraded to Buy from Hold at Deutsche Bank
02/26/23 Goldman Sachs
GSK reinstated with a Buy at Goldman Sachs
02/10/23 Berenberg
GSK price target raised to 1,730 GBp from 1,580 GBp at Berenberg
02/02/23 JPMorgan
GSK price target raised to 1,400 GBp from 1,350 GBp at JPMorgan
ANAB AnaptysBio
$21.89 /

+0.48 (+2.24%)

GSK GSK
$35.04 /

+0.65 (+1.89%)

GSK GSK
$35.04 /

+0.65 (+1.89%)

ANAB AnaptysBio
$21.89 /

+0.48 (+2.24%)

GSK GSK
$35.04 /

+0.65 (+1.89%)

GSK GSK
$35.04 /

+0.65 (+1.89%)

Hot Stocks
Berkshire Hathaway acquires over 4.4M Occidental shares » 18:52
03/27/23
03/27
18:52
03/27/23
18:52
BRK.A

Berkshire Hathaway

$458,300.00 /

+3677.07 (+0.81%)

, BRK.B

Berkshire Hathaway

$302.06 /

+3.04 (+1.02%)

, OXY

Occidental Petroleum

$59.65 /

+1.47 (+2.53%)

In a regulatory filing,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
BRK.A Berkshire Hathaway
$458,300.00 /

+3677.07 (+0.81%)

BRK.B Berkshire Hathaway
$302.06 /

+3.04 (+1.02%)

OXY Occidental Petroleum
$59.65 /

+1.47 (+2.53%)

BRK.A Berkshire Hathaway
$458,300.00 /

+3677.07 (+0.81%)

03/20/23 Gordon Haskett
After rumors, Gordon Haskett suggests Buffett could 'start at home' with Ally
02/26/23 Keefe Bruyette
Berkshire price target lowered to $480,000 from $500,000 at Keefe Bruyette
02/07/23 UBS
Berkshire can outperform given uncertain economy, says UBS
11/06/22 Keefe Bruyette
Berkshire price target lowered to $495,000 from $500,000 at Keefe Bruyette
BRK.B Berkshire Hathaway
$302.06 /

+3.04 (+1.02%)

09/21/22 Edward Jones
Berkshire Hathaway upgraded to Buy from Hold at Edward Jones
08/23/22 Gordon Haskett
Berkshire largest Celanese holder behind Vanguard, says Gordon Haskett
06/23/22 Truist
Truist ups Occidental target to 'Street high' $93, sees good odds of Buffett bid
05/01/22 Keefe Bruyette
Berkshire price target lowered to $560,000 from $565,000 at Keefe Bruyette
OXY Occidental Petroleum
$59.65 /

+1.47 (+2.53%)

08:32 Today Morgan Stanley
Occidental Petroleum price target lowered to $62 from $71 at Morgan Stanley
03/17/23 Barclays
Occidental Petroleum price target raised to $78 from $70 at Barclays
03/10/23 Mizuho
Occidental Petroleum price target raised to $83 from $82 at Mizuho
02/22/23 Evercore ISI
Occidental Petroleum downgraded to Underperform from In Line at Evercore ISI
BRK.A Berkshire Hathaway
$458,300.00 /

+3677.07 (+0.81%)

BRK.B Berkshire Hathaway
$302.06 /

+3.04 (+1.02%)

OXY Occidental Petroleum
$59.65 /

+1.47 (+2.53%)

BRK.A Berkshire Hathaway
$458,300.00 /

+3677.07 (+0.81%)

BRK.B Berkshire Hathaway
$302.06 /

+3.04 (+1.02%)

BRK.A Berkshire Hathaway
$458,300.00 /

+3677.07 (+0.81%)

BRK.B Berkshire Hathaway
$302.06 /

+3.04 (+1.02%)

OXY Occidental Petroleum
$59.65 /

+1.47 (+2.53%)

OXY Occidental Petroleum
$59.65 /

+1.47 (+2.53%)

Hot Stocks
GSK says Phase III Ruby trial demonstrates Jemperli plus chemotherapy potential » 18:22
03/27/23
03/27
18:22
03/27/23
18:22
GSK

GSK

$35.04 /

+0.65 (+1.89%)

GSK announced interim…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
GSK GSK
$35.04 /

+0.65 (+1.89%)

GSK GSK
$35.04 /

+0.65 (+1.89%)

03/17/23 Deutsche Bank
GSK upgraded to Buy from Hold at Deutsche Bank
02/26/23 Goldman Sachs
GSK reinstated with a Buy at Goldman Sachs
02/10/23 Berenberg
GSK price target raised to 1,730 GBp from 1,580 GBp at Berenberg
02/02/23 JPMorgan
GSK price target raised to 1,400 GBp from 1,350 GBp at JPMorgan
GSK GSK
$35.04 /

+0.65 (+1.89%)

GSK GSK
$35.04 /

+0.65 (+1.89%)

GSK GSK
$35.04 /

+0.65 (+1.89%)

GSK GSK
$35.04 /

+0.65 (+1.89%)

Periodicals
Judge says Amazon must face consumer antitrust suit, Reuters reports » 18:03
03/27/23
03/27
18:03
03/27/23
18:03
AMZN

Amazon.com

$98.11 /

-0.02 (-0.02%)

U.S. District Judge…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
AMZN Amazon.com
$98.11 /

-0.02 (-0.02%)

AMZN Amazon.com
$98.11 /

-0.02 (-0.02%)

03/24/23 Barclays
Meta Platforms price target raised to $270 from $260 at Barclays
03/21/23 Loop Capital
Best Buy price gap relative to Amazon widens, says Loop Capital
03/21/23 JMP Securities
JMP analysis of Amazon data shows Peloton position strengthening
03/21/23 Citi
Citi says Amazon becoming more profitable with job cuts
AMZN Amazon.com
$98.11 /

-0.02 (-0.02%)

AMZN Amazon.com
$98.11 /

-0.02 (-0.02%)

AMZN Amazon.com
$98.11 /

-0.02 (-0.02%)

AMZN Amazon.com
$98.11 /

-0.02 (-0.02%)

Hot Stocks
Tejon Ranch considering options to proceed with development of Centennial » 17:58
03/27/23
03/27
17:58
03/27/23
17:58
TRC

Tejon Ranch

$18.26 /

+0.76 (+4.34%)

Los Angeles Superior…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
TRC Tejon Ranch
$18.26 /

+0.76 (+4.34%)

TRC Tejon Ranch
$18.26 /

+0.76 (+4.34%)

On The Fly
Fly Intel: After-Hours Movers » 17:57
03/27/23
03/27
17:57
03/27/23
17:57
PVH

PVH Corp.

$73.62 /

+0.71 (+0.97%)

, LYFT

Lyft

$9.62 /

-0.26 (-2.63%)

, RAIL

FreightCar America

$3.17 /

+ (+0.00%)

HIGHER AFTER EARNINGS …

ShowHide Related Items >><<
PVH PVH Corp.
$73.62 /

+0.71 (+0.97%)

LYFT Lyft
$9.62 /

-0.26 (-2.63%)

RAIL FreightCar America
$3.17 /

+ (+0.00%)

PVH PVH Corp.
$73.62 /

+0.71 (+0.97%)

03/21/23 UBS
PVH Corp. price target lowered to $92 from $100 at UBS
03/20/23 Goldman Sachs
PVH Corp. price target raised to $74 from $67 at Goldman Sachs
02/15/23 Wells Fargo
PVH Corp. price target raised to $110 from $85 at Wells Fargo
01/23/23 JPMorgan
PVH Corp. price target raised to $95 from $77 at JPMorgan
LYFT Lyft
$9.62 /

-0.26 (-2.63%)

03/15/23 Deutsche Bank
Lyft price target raised to $12 from $11 at Deutsche Bank
03/14/23 Jefferies
California ruling a 'big win' for Uber, Lyft and DoorDash, says Jefferies
02/14/23 Argus
Lyft downgraded to Hold from Buy at Argus
02/14/23 BTIG
Lyft downgraded to Neutral from Buy at BTIG
RAIL FreightCar America
$3.17 /

+ (+0.00%)

PVH PVH Corp.
$73.62 /

+0.71 (+0.97%)

LYFT Lyft
$9.62 /

-0.26 (-2.63%)

RAIL FreightCar America
$3.17 /

+ (+0.00%)

LYFT Lyft
$9.62 /

-0.26 (-2.63%)

PVH PVH Corp.
$73.62 /

+0.71 (+0.97%)

LYFT Lyft
$9.62 /

-0.26 (-2.63%)

PVH PVH Corp.
$73.62 /

+0.71 (+0.97%)

LYFT Lyft
$9.62 /

-0.26 (-2.63%)

Hot Stocks
TD Synnex names John Henry chief accounting officer » 17:53
03/27/23
03/27
17:53
03/27/23
17:53
SNX

TD Synnex

$92.97 /

+1.455 (+1.59%)

According to a regulatory…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
SNX TD Synnex
$92.97 /

+1.455 (+1.59%)

SNX TD Synnex
$92.97 /

+1.455 (+1.59%)

02/15/23 Barclays
TD Synnex initiated with an Equal Weight at Barclays
01/11/23 Barrington
TD Synnex price target raised to $130 from $98 at Barrington
01/11/23 Credit Suisse
TD Synnex price target raised to $109 from $103 at Credit Suisse
12/21/22 Citi
Citi reveals top IT hardware stock picks for 2023
SNX TD Synnex
$92.97 /

+1.455 (+1.59%)

  • 26
    Jan
SNX TD Synnex
$92.97 /

+1.455 (+1.59%)

Earnings
StarTek reports Q4 adjusted EPS 35c vs 32c last year » 17:52
03/27/23
03/27
17:52
03/27/23
17:52
SRT

StarTek

$3.99 /

+0.26 (+6.97%)

Reports Q4 revenue $92.96…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
SRT StarTek
$3.99 /

+0.26 (+6.97%)

SRT StarTek
$3.99 /

+0.26 (+6.97%)

Earnings
FreightCar America sees FY23 revenue $400M-$430M » 17:48
03/27/23
03/27
17:48
03/27/23
17:48
RAIL

FreightCar America

$3.17 /

+ (+0.00%)

Sees FY23 adjusted EBITDA…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
RAIL FreightCar America
$3.17 /

+ (+0.00%)

RAIL FreightCar America
$3.17 /

+ (+0.00%)

Earnings
FreightCar America reports Q4 adjusted EPS (31c), two estimates (11c) » 17:48
03/27/23
03/27
17:48
03/27/23
17:48
RAIL

FreightCar America

$3.17 /

+ (+0.00%)

Reports Q4 revenue $129M,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
RAIL FreightCar America
$3.17 /

+ (+0.00%)

Hot Stocks
Retractable Technologies cuts workforce by roughly 22% » 17:37
03/27/23
03/27
17:37
03/27/23
17:37
RVP

Retractable Technologies

$1.76 /

+0.03 (+1.73%)

Retractable Technologies…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
RVP Retractable Technologies
$1.76 /

+0.03 (+1.73%)

Earnings
Excelerate Energy sees FY23 adjusted EBITDA $320M-$340M  17:37
03/27/23
03/27
17:37
03/27/23
17:37
EE

Excelerate Energy

$19.71 /

+0.77 (+4.07%)

 
ShowHide Related Items >><<
EE Excelerate Energy
$19.71 /

+0.77 (+4.07%)

EE Excelerate Energy
$19.71 /

+0.77 (+4.07%)

07/20/22 Barclays
Excelerate Energy price target lowered to $27 from $33 at Barclays
07/05/22 Wells Fargo
Wells Fargo upgrades Excelerate Energy to Overweight with $29 price target
07/05/22 Wells Fargo
Excelerate Energy upgraded to Overweight from Equal Weight at Wells Fargo
05/09/22 Morgan Stanley
Excelerate Energy initiated with an Equal Weight at Morgan Stanley
EE Excelerate Energy
$19.71 /

+0.77 (+4.07%)

  • 13
    Apr
Earnings
Excelerate Energy reports Q4 EPS 25c, consensus 22c » 17:36
03/27/23
03/27
17:36
03/27/23
17:36
EE

Excelerate Energy

$19.71 /

+0.77 (+4.07%)

Reports Q4 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
EE Excelerate Energy
$19.71 /

+0.77 (+4.07%)

EE Excelerate Energy
$19.71 /

+0.77 (+4.07%)

07/20/22 Barclays
Excelerate Energy price target lowered to $27 from $33 at Barclays
07/05/22 Wells Fargo
Wells Fargo upgrades Excelerate Energy to Overweight with $29 price target
07/05/22 Wells Fargo
Excelerate Energy upgraded to Overweight from Equal Weight at Wells Fargo
05/09/22 Morgan Stanley
Excelerate Energy initiated with an Equal Weight at Morgan Stanley
EE Excelerate Energy
$19.71 /

+0.77 (+4.07%)

  • 13
    Apr
Hot Stocks
Monopar Therapeutics Inc trading resumes  17:30
03/27/23
03/27
17:30
03/27/23
17:30
MNPR

Monopar Therapeutics

$2.90 /

-0.09 (-3.01%)

 
ShowHide Related Items >><<
MNPR Monopar Therapeutics
$2.90 /

-0.09 (-3.01%)

MNPR Monopar Therapeutics
$2.90 /

-0.09 (-3.01%)

01/23/23 EF Hutton
Monopar Therapeutics initiated with a Buy at EF Hutton
12/09/22 Roth Capital
Monopar Therapeutics resumed with a Buy at Roth Capital
08/16/22 H.C. Wainwright
Monopar Therapeutics price target lowered to $6 from $9 at H.C. Wainwright
MNPR Monopar Therapeutics
$2.90 /

-0.09 (-3.01%)

Hot Stocks
Lockheed Martin awarded $210.09M government contract » 17:24
03/27/23
03/27
17:24
03/27/23
17:24
LMT

Lockheed Martin

$473.25 /

-1.11 (-0.23%)

Lockheed Martin was…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
LMT Lockheed Martin
$473.25 /

-1.11 (-0.23%)

LMT Lockheed Martin
$473.25 /

-1.11 (-0.23%)

02/21/23 BofA
F-35 re-engining an underappreciated opportunity for GE, says BofA
02/06/23 Credit Suisse
Lockheed Martin double upgraded to Outperform at Credit Suisse
02/06/23 Credit Suisse
Lockheed Martin upgraded to Outperform from Underperform at Credit Suisse
01/30/23 DZ Bank
Lockheed Martin upgraded to Buy from Hold at DZ Bank
LMT Lockheed Martin
$473.25 /

-1.11 (-0.23%)

LMT Lockheed Martin
$473.25 /

-1.11 (-0.23%)

LMT Lockheed Martin
$473.25 /

-1.11 (-0.23%)

LMT Lockheed Martin
$473.25 /

-1.11 (-0.23%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.